Atsushi Sugimura

Title: Atsushi Sugimura: Innovator in Hematopoietic Stem Cell Research

Introduction

Atsushi Sugimura is a notable inventor based in Hokkaido, Japan. He has made significant contributions to the field of hematopoietic stem cell research. His innovative work has the potential to impact the diagnosis and treatment of various hematopoietic diseases.

Latest Patents

Atsushi Sugimura holds a patent for a novel polypeptide known as the hematopoietic stem cell growth factor (SCGF). This invention provides a polypeptide that possesses growth activities on hematopoietic stem cells, along with a gene encoding the polypeptide and an antibody that reacts specifically with it. The patent also includes a method for isolating the SCGF gene and a vector for use in this method. This invention aims to elucidate the pathogenesis of hematopoietic diseases and improve the efficiency of gene transfer into hematopoietic stem cells for gene therapy.

Career Highlights

Throughout his career, Atsushi Sugimura has focused on advancing the understanding of hematopoietic stem cells. His work has contributed to the technological progress in genetic engineering, particularly in the context of bone marrow transplantation and the treatment of hematopoietic diseases.

Collaborations

Atsushi Sugimura has collaborated with notable colleagues, including Atsunobu Hiraoka and Hiroyuki Mio. Their combined efforts have furthered research in the field of hematopoietic stem cells.

Conclusion

Atsushi Sugimura's innovative contributions to hematopoietic stem cell research highlight the importance of his work in advancing medical science. His patent for the SCGF represents a significant step forward in understanding and treating hematopoietic diseases.